Relationship between antibody levels and SARS-Cov-2 reinfection

Date
12.2021Author
İslamoğlu, Mehmet SamiCengiz, Mahir
Börkü Uysal, Betül
İkitimur, Hande
Özdemir, Zeynep
Karamehmetoğlu, Ahsen
Akbulut, Ayşe Ezgi
Bakdur, Ayşe Nur
Özdemir, Azize
Kayıkçıoğlu, Habibe
Özdemir, Hatice
Üçeş, Rümeysa
Ersoy, Sema
Yavuzer, Serap
Metadata
Show full item recordAbstract
Objective: In this period when mutant strains are increasing all over the world, studies on how much humoral immunity will protect against the Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) are quite limited. The aim of our study is to investigate the positivity and antibody levels of the COVID-19 reverse transcription polymerase chain reaction (RT-PCR) test, the frequency of SARS-CoV-2 re-infection, and the protective antibody level against re-infection. Methods: Patients who were positive for COVID-19 IgG antibody between 1 July and 31 August were included in our study. The COVID-19 RT-PCR test positivity, age, gender and comorbidities of these patients were recorded before this date. The COVID-19 RT-PCR test positivity of these patients was followed from the National COVID-19 Database between September 1, 2020 and February 28, 2021. Results: 1665 patients (female: male 683: 982, mean age 40.6±13.4 years). Among all patients, 14 patients had reinfection and the frequency of reinfection was 0.8%. It was observed that the frequency of reinfection was more frequent in patients with PCR negative (p<0.001). The IgG cut-off value causing reinfection was found to be 11.9 (AUC: 0.844, 79.2% sensitivity, 78.6% specificity) (p<0.001). Conclusion: Humoral antibodies against SARS-CoV-2 were protective against COVID-19 reinfection, 0.8% of the patients had reinfection and the resultant reinfection was mostly seen in PCR negative patients who were asymptomatic.
Source
Annals of Clinical & Laboratory ScienceVolume
51Issue
6Collections
The following license files are associated with this item: